pantoprazole has been researched along with Lupus Erythematosus, Cutaneous in 4 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Lupus Erythematosus, Cutaneous: A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almebayadh, M | 1 |
| Regnier-Rosencher, E | 1 |
| Carlotti, A | 1 |
| Goulvestre, C | 1 |
| Le Guern, V | 1 |
| Mouthon, L | 1 |
| Avril, MF | 1 |
| Dupin, N | 1 |
| Schmutz, JL | 1 |
| Trechot, P | 1 |
| Jones, EK | 1 |
| Mingioni, N | 1 |
| Lee, JB | 1 |
| Dam, C | 1 |
| Bygum, A | 1 |
4 other studies available for pantoprazole and Lupus Erythematosus, Cutaneous
| Article | Year |
|---|---|
Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Esomeprazole; Female; Humans; Lupus Erythematosus, C | 2013 |
[Lupus erythematosus and proto-pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Autoantibodies; Biopsy; Diagnosis, Differential; Eso | 2014 |
Widespread Scaly Eruption in a Patient With Multiple Comorbidities.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Comorbidity; Drug Eruptions; Female; Humans; Lupus Er | 2015 |
Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Autoantibodies; Duodenal Ulcer; Esophagitis; Female; Humans | 2008 |